DUBLIN--(BUSINESS WIRE)--The "Tissue Diagnostics Market by Product (Antibodies, Kits, Slide Staining System, Tissue Processing System), Technology (ISH, IHC, Special Staining), Disease (Breast Cancer, NSCLC, Lymphoma), End User (Hospitals, Research Laboratories)-Global Forecast to 2025" report has been added to ResearchAndMarkets.com's offering.
The global tissue diagnostics market is expected to reach USD 4.72 billion by 2025 from USD 3.44 billion in 2020, at a CAGR of 6.5%.
The growth in this market is driven by the rising incidence of cancer, developing infrastructure for cancer diagnosis, the recommendation of cancer screening, availability of reimbursements, and increasing healthcare expenditure.
The consumables segment is anticipated to grow at the fastest growth rate during the forecast period.
Based on product type, the tissue diagnostics market is segmented into instruments and consumables. The consumables segment is expected to grow at the highest growth rate during the forecast period. The large market share of this segment is driven mainly by their requirement in large numbers, cost-effectiveness, and ease of use. The increasing number of reagent rental agreements is also one of the major factors to drive the growth of the consumables market globally.
The immunohistochemistry segment is estimated to grow at a rapid rate during the analysis period.
Based on the technology type, the tissue diagnostic market is segmented into immunohistochemistry, in situ hybridization, digital pathology and workflow, and special staining. The immunohistochemistry segment is estimated to register the highest CAGR during the forecast period. This can primarily be attributed to is increasing prevalence of chronic diseases across the globe, where this technology is mostly used in tissue diagnostics.
Asia Pacific is estimated to register the highest CAGR during the study period.
Geographically, the tissue diagnostic market is dominated by North America and followed by Europe in 2019. However, the Asia Pacific region is estimated to grow at the fastest rate during forecast to period. Economic growth in the countries of this region, large population base, rising prevalence of chronic diseases, a rising standard of living, growing demand for quality medical care, increasing healthcare spending, increasing government initiatives, and rising awareness regarding the use of tissue diagnostic tests, will drive the market in the region over the forecast period.
- Increasing Incidence of Cancer
- Growing Healthcare Expenditure
- Developing Infrastructure for Cancer Diagnosis
- Recommendations for Cancer Screening
- Availability of Reimbursements
- High Degree of Consolidation
- Significant Opportunities in Brics Countries
- Growing Demand for Personalized Medicines
- Increasing Number of Clinical Trials Pertaining to Cancer Drugs
- Stringent Regulatory Requirements
- Lack of Infrastructure and Low Awareness in Middle- and Low- Income Countries
- Availability of Refurbished Products
- Lack of Skilled Professionals
- Product Failures and Recalls
Increasing Number of Reagent Rental Agreements
- Thermo Fisher Scientific
- Agilent Technologies
- Merck Kgaa
- Sakura Finetek Japan
- Becton, Dickinson and Company (Bd)
- Bio Sb
- Cell Signaling Technology
- Histo-Line Laboratories
- Slee Medical Gmbh
- Amos Scientific Pty Ltd
- Jinhua Yidi Medical Appliance Co.Ltd
- Medite Gmbh
- Cellpath Ltd
- Hologic, Inc.
For more information about this report visit https://www.researchandmarkets.com/r/i9vffh